Combination therapy with rituximab may benefit elderly patients with DLBCL Healio In elderly patients with diffuse large B-cell lymphoma, a combination therapy regimen that includes rituximab appears to yield successful response rates, according to recent study findings published in Thyroid. In the study, researchers retrospectively ... |
